1
Investment Banking Group
0000 Xxxxx Xxxxx
Xxxxxxx, Xxxxxxxx 00000
000 000 0000
FAX 000 000 0000
[Xxxxxxx Xxxxx Logo]
January 31, 1996
Board of Directors
DEKALB Genetics Corporation
0000 Xxxxxxxx Xxxx
XxXxxx, Xxxxxxxx 00000
Gentlemen:
DEKALB Genetics Corporation (the "Company") and Monsanto Company (the
"Partner") propose to enter into certain agreements pursuant to which (i) the
Company will issue shares of Class A voting stock, without par value (the "Class
A Stock"), at a purchase price of $65 per share in cash (such shares to
represent 10% of the outstanding shares of Class A Stock after expiration of the
Offer and after giving effect to the issuance thereof) and 378,000 shares of
Class B non-voting stock, without par value (the "Class B Stock"), at a purchase
price of $65 per share in cash to the Partner pursuant to an Investment
Agreement, dated January 31, 1996, between the Company and the Partner (the
"Investment Agreement"); (ii) the Partner will make a tender offer to the
holders of shares of Class B Stock for up to 1.8 million shares of the Class B
Stock, at $71 per share, net to such holders in cash pursuant to the terms and
conditions of the Investment Agreement; and (iii) the Company and the Partner
will collaborate in the development and marketing of certain products pursuant
to certain Collaboration and Licensing Agreements, dated January 31, 1996,
between the Company and the Partner (the "Collaboration Agreements"). The
transactions contemplated by the Investment Agreement and the Collaboration
Agreements are collectively referred to herein as the "Transactions."
You have asked us whether, in our opinion, the Transactions, taken as a
whole, are fair to the Company and its shareholders from a financial point of
view.
In arriving at the opinion set forth below, we have, among other things:
(1) Reviewed the Company's Annual Reports, Forms 10-K and related
financial information for the five fiscal years ended August 30, 1995;
(2) Reviewed certain information, including financial forecasts,
relating to the business, earnings, cash flow, assets and prospects of the
Company, furnished to us by the Company;
(3) Conducted discussions with members of senior management of the
Company concerning its businesses and prospects and the prospects of the
relevant assets of the Partner;
(4) Reviewed the historical market prices and trading activity for the
Shares and compared them with that of certain publicly traded companies
which we deemed to be reasonably similar to the Company;
(5) Compared the results of operations of the Company with that of
certain companies which we deemed to be reasonably similar to the Company;
2
(6) Compared the proposed financial terms of the Transactions with the
financial terms of certain other strategic alliances which we deemed to be
relevant;
(7) Reviewed drafts of the Collaboration Agreements and Investment
Agreement dated January 31, 1996; and
(8) Reviewed such other financial studies and analyses and performed
such other investigations and took into account such other matters as we
deemed necessary.
In preparing our opinion, we have assumed and relied upon the accuracy and
completeness of all information that was available to us from public sources and
that was supplied or otherwise made available to us by the Company. We have not
assumed any responsibility for independent verification of such information or
any independent valuation or appraisal of any of the tangible or intangible
assets of the Company. With respect to the financial forecasts furnished by the
Company, we have assumed that they have been reasonably prepared and reflect the
best currently available estimates and judgment of the Company's management as
to the expected future financial performance of the Company and the financial
effects of the Collaboration Agreements. In connection with the preparation of
this opinion, we have not been authorized to solicit, nor have we solicited or
evaluated, any alternative transactions with third parties. Our opinion is based
upon market, economic, financial and other conditions as they exist and can be
evaluated as of the date hereof.
Our opinion set forth below is directed to the Board of Directors of the
Company and does not constitute a recommendation to any stockholder of the
Company with respect to the Transactions or as to whether they should tender
their shares of Class B Stock pursuant to the Offer.
We have acted as financial advisor to the Board of Directors of the Company
in connection with the Transactions and will receive a fee for our services,
which is conditioned upon the completion of the Transactions. In the ordinary
course of our business, we and our affiliates may actively trade the debt and
equity securities of the Company and the Partner for our or their own accounts
and for the accounts of customers and, accordingly, may at any time hold a long
or short position in such securities. We have, in the past, also provided
financial advisory services to the Company and the Partner and have received
fees for the rendering of such services.
On the basis of, and subject to the foregoing, we are of the opinion that,
as of the date hereof, the proposed Transactions, taken as a whole, are fair to
the Company and its shareholders from a financial point of view.
Very truly yours,
XXXXXXX LYNCH, XXXXXX, XXXXXX &
XXXXX INCORPORATED
By /s/ Xxxxxxx Xxxxxxxxx
------------------------------------
Investment Banking Group
